Copyright
©The Author(s) 2016.
World J Psychiatr. Dec 22, 2016; 6(4): 419-430
Published online Dec 22, 2016. doi: 10.5498/wjp.v6.i4.419
Published online Dec 22, 2016. doi: 10.5498/wjp.v6.i4.419
Table 1 Groups of mental disorders and risk factors in the PsyCoLaus study: Frequencies and crude odds ratios (with 95%CI), overall and by sex
n (%) | Education level low | Education level medium | Education level high | Familial aggregation6 | Trauma below age of 10 | Childhood adversities7 | Streptococcal diseases8 | MMR | Peptic ulcer/gastritis | Irritable bowel syndrome | Atopic diseases | Acne | Psoriasis | Urinary tract infections9 | |
Total n (%) | |||||||||||||||
All | 3720 (100.0) | 1965 (53.4) | 916 (24.9) | 798 (21.7) | 2071 (55.7) | 160 (4.3) | 1013 (27.2) | 230 (6.2) | 3033 (86.7) | 317 (6.5) | 187 (3.8) | 2129 (43.8) | 474 (9.7) | 220 (4.5) | 844 (22.7) |
Males | 1750 (47.0) | 888 (51.3) | 366 (21.1) | 477 (27.6) | 876 (50.1) | 45 (2.6) | 417 (23.8) | 87 (5.0) | 1353 (83.2) | 159 (7.0) | 52 (2.3) | 895 (39.6) | 191 (8.4) | 108 (4.8) | 86 (4.9) |
Females | 1970 (53.0) | 1077 (55.3) | 550 (28.2) | 321 (16.5) | 1195 (60.7) | 115 (5.8) | 596 (30.3) | 143 (7.3) | 1226 (89.6) | 158 (6.1) | 135 (5.2) | 1234 (47.4) | 283 (10.9) | 112 (4.3) | 758 (38.5) |
Odds ratios | |||||||||||||||
Neurodevelop- mental disorders1 | |||||||||||||||
All | 308 (8.3) | 1 (ref) | 1.17 (0.89-1.55) | 0.94 (0.69-1.29) | 1.75 (1.26-2.42) | 1.93 (1.22-3.05) | 2.93 (2.31-3.71) | 1.67 (1.11-2.50) | 1.18 (0.83-1.67) | 1.68 (1.14-2.49) | 1.74 (1.07-2.83) | 0.98 (0.78-1.24) | 0.87 (0.59-1.29) | 1.07 (0.63-1.80) | 1.13 (0.86-1.48) |
Males | 189 (10.8) | 1 (ref) | 1.39 (0.96-2.00) | 0.85 (0.58-1.24) | 1.98 (1.27-3.10) | 1.28 (0.53-3.06) | 3.10 (2.27-4.23) | 2.65 (1.57-4.48) | 1.35 (0.87-2.08) | 1.52 (0.89-2.57) | 2.18 (1.03-4.61) | 1.15 (0.85-1.56) | 0.88 (0.50-1.53) | 1.09 (0.57-2.08) | 1.36 (0.73-2.56) |
Females | 119 (6.0) | 1 (ref) | 1.03 (0.67-1.57) | 0.93 (0.54-1.58) | 1.75 (1.08-2.85) | 2.98 (1.72-5.12) | 3.22 (2.21-4.69) | 1.05 (0.52-2.11) | 1.13 (0.63-2.04) | 1.94 (1.08-3.49) | 1.86 (0.97-3.58) | 0.89 (0.62-1.30) | 0.97 (0.55-1.72) | 0.93 (0.37-2.35) | 1.94 (1.34-2.82) |
Early anxiety disorders2 | |||||||||||||||
All | 951 (25.6) | 1 (ref) | 0.98 (0.82-1.17) | 0.93 (0.77-1.12) | 2.75 (2.36-3.21) | 1.96 (1.41-2.71) | 1.85 (1.58-2.17) | 1.51 (1.13-2.00) | 1.43 (1.12-1.81) | 1.33 (1.01-1.76) | 2.42 (1.74-3.37) | 1.23 (1.06-1.43) | 1.32 (1.05-1.66) | 1.41 (1.03-1.94) | 1.90 (1.61-2.24) |
Males | 327 (18.7) | 1 (ref) | 1.03 (0.76-1.41) | 1.06 (0.80-1.41) | 2.48 (1.93-3.20) | 2.01 (1.06-3.82) | 2.01 (1.55-2.61) | 1.71 (1.05-2.78) | 1.27 (0.89-1.80) | 1.75 (1.15-2.66) | 2.84 (1.53-5.27) | 1.03 (0.81-1.31) | 1.59 (1.08-2.32) | 2.22 (1.42-3.48) | 1.25 (0.74-2.11) |
Females | 624 (31.7) | 1 (ref) | 0.90 (0.72-1.13) | 1.01 (0.77-1.32) | 2.76 (2.26-3.36) | 1.65 (1.13-2.42) | 1.65 (1.35-2.02) | 1.29 (0.91-1.84) | 1.35 (0.96-1.88) | 1.11 (0.77-1.61) | 1.97 (1.33-2.92) | 1.25 (1.03-1.51) | 1.11 (0.83-1.47) | 1.01 (0.64-1.59) | 1.51 (1.24-1.83) |
Late anxiety disorders3 | |||||||||||||||
All | 554 (14.9) | 1 (ref) | 0.96 (0.77-1.20) | 0.82 (0.64-1.04) | 2.15 (1.67-2.76) | 1.64 (1.12-2.42) | 1.92 (1.59-2.32) | 1.38 (0.98-1.94) | 1.44 (1.07-1.95) | 1.66 (1.21-2.27) | 2.30 (1.59-3.32) | 1.34 (1.12-1.61) | 1.13 (0.85-1.49) | 1.13 (0.75-1.69) | 1.49 (1.22-1.82) |
Males | 200 (11.4) | 1 (ref) | 1.14 (0.78-1.67) | 1.22 (0.87-1.72) | 1.96 (1.24-3.08) | 0.97 (0.38-2.48) | 1.60 (1.16-2.20) | 1.01 (0.51-1.99) | 1.03 (0.68-1.56) | 1.32 (0.77-2.25) | 2.04 (0.97-4.31) | 1.19 (0.89-1.61) | 1.56 (0.99-2.46) | 0.70 (0.33-1.47) | 2.68 (1.60-4.49) |
Females | 354 (18.0) | 1 (ref) | 0.84 (0.65-1.11) | 0.64 (0.45-0.92) | 2.06 (1.53-2.79) | 1.67 (1.08-2.57) | 2.02 (1.59-2.55) | 1.47 (0.98-2.20) | 1.75 (1.11-2.75) | 1.93 (1.29-2.86) | 2.14 (1.39-3.29) | 1.35 (1.07-1.69) | 0.88 (0.61-1.27) | 1.56 (0.95-2.56) | 1.06 (0.83-1.34) |
Mood disorders4 | |||||||||||||||
All | 1765 (47.4) | 1 (ref) | 1.21 (1.03-1.41) | 0.99 (0.84-1.16) | 2.14 (1.87-2.45) | 1.90 (1.37-2.63) | 2.07 (1.79-2.40) | 1.05 (0.80-1.38) | 1.18 (0.97-1.44) | 1.71 (1.32-2.22) | 2.31 (1.63-3.26) | 1.27 (1.11-1.44) | 1.29 (1.05-1.59) | 1.45 (1.07-1.96) | 2.19 (1.87-2.56) |
Males | 628 (35.9) | 1 (ref) | 1.43 (1.11-1.84) | 1.26 (1.00-1.59) | 1.93 (1.57-2.37) | 1.91 (1.05-3.44) | 1.85 (1.48-2.31) | 1.01 (0.51-1.69) | 1.15 (0.88-1.52) | 1.70 (1.17-2.47) | 1.65 (0.91-3.00) | 1.29 (1.06-1.57) | 1.76 (1.27-2.45) | 1.38 (0.91-2.09) | 2.04 (1.32-3.14) |
Females | 1137 (57.7) | 1 (ref) | 1.00 (0.82-1.24) | 1.02 (0.79-1.31) | 2.08 (1.73-2.50) | 1.52 (1.02-2.27) | 2.12 (1.72-2.60) | 1.01 (0.72-1.43) | 0.93 (0.70-1.26) | 1.83 (1.25-2.69) | 2.25 (1.44-3.52) | 1.09 (0.91-1.30) | 0.93 (0.71-1.23) | 1.79 (1.12-2.85) | 1.47 (1.22-1.77) |
Substance abuse/ dependence5 | |||||||||||||||
All | 576 (15.5) | 1 (ref) | 0.77 (0.61-0.96) | 0.89 (0.71-1.12) | 2.10 (1.62-2.72) | 1.22 (0.81-1.84) | 1.82 (1.51-2.19) | 0.89 (0.56-1.40) | 0.90 (0.69-1.17) | 1.55 (1.13-2.12) | 1.26 (0.83-1.92) | 0.97 (0.81-1.16) | 1.17 (0.89-1.54) | 1.42 (0.98-2.06) | 0.78 (0.61-0.98) |
Males | 429 (24.5) | 1 (ref) | 0.82 (0.62-1.09) | 0.66 (0.51-0.87) | 2.65 (1.87-3.75) | 1.00 (0.50-1.98) | 1.94 (1.52-2.47) | 0.98 (0.59-1.62) | 0.98 (0.73-1.33) | 1.62 (1.09-2.41) | 1.79 (0.96-3.35) | 1.12 (0.90-1.40) | 1.64 (1.15-2.33) | 1.24 (0.78-1.97) | 1.36 (0.84-2.18) |
Females | 147 (7.5) | 1 (ref) | 0.80 (0.53-1.21) | 1.00 (0.63-1.59) | 2.11 (1.35-3.29) | 2.48 (1.46-4.24) | 2.60 (1.85-3.65) | 0.82 (0.41-1.65) | 1.58 (0.82-3.06) | 1.53 (0.86-2.74) | 1.64 (0.88-3.07) | 1.06 (0.75-1.48) | 0.89 (0.52-1.53) | 1.66 (0.84-3.28) | 1.41 (1.01-1.98) |
Table 2 Mental disorders regressed on infectious, atopic and inflammatory diseases, odds-ratios and 95%CI derived from logistic regression models
Model 1 Neurodevelopmental disorders | Model 2 Early anxiety disorders | Model 3 Late anxiety disorders | Model 4 Mood disorders | Model 5 Substance abuse/ dependence | |
Sex | 0.38 (0.27-0.52) | 1.60 (1.33-1.94) | 1.50 (1.19-1.87) | 2.05 (1.74-2.41) | 0.19 (0.14-0.24) |
Education level | |||||
Low | 1 (ref) | 1 (ref) | 1 (ref) | 1 (ref) | 1 (ref) |
Medium | 0.91 (0.66-1.24) | 1.24 (1.01-1.52) | 1.11 (0.87-1.41) | 0.86 (0.72-1.04) | 1.19 (0.92-1.54) |
High | 1.10 (0.78-1.56) | 1.08 (0.87-1.34) | 1.07 (0.83-1.39) | 0.88 (0.72-1.06) | 1.27 (0.98-1.66) |
Familial aggregation of CMD | 1.55 (1.07-2.23) | 2.54 (2.14-3.01) | 1.75 (1.34-2.29) | 1.77 (1.52-2.06) | 2.12 (1.59-2.82) |
Trauma below age of 10 | 1.43 (0.84-2.44) | 1.07 (0.73-1.57) | 1.12 (0.73-1.71) | 1.11 (0.76-1.62) | 1.36 (0.84-2.20) |
Childhood adversities | 2.74 (2.09-3.60) | 1.51 (1.25-1.81) | 1.89 (1.53-2.33) | 1.87 (1.57-2.23) | 1.81 (1.45-2.27) |
Streptococcal infections | 1.29 (0.79-2.10) | 1.11 (0.80-1.55) | 1.22 (0.84-1.78) | 0.80 (0.59-1.10) | 0.80 (0.51-1.25) |
Mumps, measles, rubella | 1.37 (0.91-2.06) | 1.36 (1.04-1.77) | 1.33 (0.97-1.83) | 1.07 (0.86-1.34) | 1.15 (0.85-1.54) |
Peptic ulcer/gastritis | 1.72 (1.11-2.68) | 1.23 (0.89-1.71) | 1.47 (1.03-2.11) | 1.74 (1.27-2.39) | 1.58 (1.09-2.29) |
Irritable bowel syndrome | 1.30 (0.71-2.36) | 1.81 (1.24-2.64) | 1.74 (1.15-2.62) | 1.87 (1.26-2.79) | 1.70 (1.06-2.73) |
Atopic diseases | 0.95 (0.73-1.25) | 1.11 (0.94-1.31) | 1.24 (1.01-1.51) | 1.06 (0.91-1.24) | 1.02 (0.83-1.26) |
Acne | 0.83 (0.53-1.30) | 1.10 (0.85-1.43) | 1.02 (0.74-1.39) | 1.23 (0.97-1.57) | 1.27 (0.92-1.76) |
Psoriasis | 1.22 (0.69-2.16) | 1.45 (0.99-2.11) | 1.05 (0.66-1.69) | 1.59 (1.11-2.28) | 1.41 (0.91-2.19) |
Urinary tract infections | 1.51 (1.06-2.14) | 1.37 (1.12-1.67) | 1.06 (0.83-1.35) | 1.49 (1.22-1.80) | 1.20 (0.88-1.64) |
Table 3 Mental disorders regressed on infectious, atopic and inflammatory diseases, odds-ratios and 95%CIs derived from logistic regression models with nested effects
Model 1 Neurodevelopmental disorders | Model 2 Early anxiety disorders | Model 3 Late anxiety disorders | Model 4 Mood disorders | Model 5 Substance abuse/ dependence | ||
Sex | 0.41 (0.23-0.72) | 0.79 (0.54-1.15) | 1.08 (0.68-1.69) | 1.56 (1.08-2.26) | 0.34 (0.21-0.54) | |
Education level | ||||||
Low | 1 (ref) | 1 (ref) | 1 (ref) | 1 (ref) | 1 (ref) | |
Medium | 1.09 (0.79-1.49) | 0.79 (0.65-0.98) | 0.89 (0.70-1.13) | 1.15 (0.96-1.38) | 0.83 (0.64-1.08) | |
High | 0.88 (0.62-1.25) | 0.91 (0.73-1.14) | 0.92 (0.71-1.20) | 1.12 (0.92-1.36) | 0.77 (0.59-1.01) | |
Familial aggregation of CMD | 1.53 (1.06-2.21) | 2.53 (2.14-3.00) | 1.78 (1.36-2.33) | 1.77 (1.52-2.06) | 2.14 (1.60-2.86) | |
Trauma below age of 10 | 1.47 (0.86-2.50) | 1.08 (0.73-1.58) | 1.11 (0.73-1.71) | 1.12 (0.76-1.64) | 1.40 (0.86-2.27) | |
Childhood adversities | 2.78 (2.12-3.65) | 1.52 (1.26-1.83) | 1.91 (1.55-2.36) | 1.89 (1.59-2.25) | 1.83 (1.46-2.29) | |
Streptococcal infections | Women nested | 0.69 (0.29-1.67) | 1.15 (0.76-1.73) | 1.32 (0.84-2.07) | 0.91 (0.60-1.36) | 0.87 (0.42-1.82) |
Men nested | 1.98 (1.08-3.66) | 1.08 (0.60-1.92) | 1.04 (0.51-2.09) | 0.67 (0.40-1.12) | 0.78 (0.44-1.39) | |
Mumps, measles, rubella | Women nested | 1.16 (0.58-2.32) | 1.46 (1.01-2.10) | 1.81 (1.12-2.90) | 0.97 (0.70-1.35) | 1.62 (0.79-3.29) |
Men nested | 1.47 (0.88-2.45) | 1.29 (0.88-1.91) | 0.96 (0.62-1.49) | 1.12 (0.83-1.52) | 1.04 (0.74-1.46) | |
Peptic ulcer/gastritis | Women nested | 1.72 (0.88-3.34) | 0.97 (0.63-1.49) | 1.60 (1.02-2.51) | 1.58 (1.02-2.46) | 1.19 (0.61-2.35) |
Men nested | 1.95 (1.08-3.53) | 1.85 (1.13-3.05) | 1.25 (0.67-2.35) | 1.98 (1.26-3.09) | 1.88 (1.18-2.99) | |
Irritable bowel syndrome | Women nested | 1.23 (0.56-2.70) | 1.48 (0.95-2.30) | 1.60 (0.99-2.57) | 2.25 (1.35-3.76) | 1.63 (0.84-3.16) |
Men nested | 1.74 (0.70-4.36) | 3.15 (1.58-6.28) | 1.97 (0.86-2.48) | 1.33 (0.67-2.62) | 1.80 (0.90-3.61) | |
Atopic diseases | Women nested | 0.74 (0.48-1.12) | 1.19 (0.96-1.47) | 1.28 (0.99-1.66) | 0.97 (0.79-1.18) | 1.02 (0.69-1.49) |
Men nested | 1.14 (0.80-1.61) | 1.02 (0.77-1.34) | 1.19 (0.86-1.66) | 1.22 (0.97-1.53) | 1.05 (0.81-1.35) | |
Acne | Women nested | 0.75 (0.39-1.47) | 0.94 (0.68-1.31) | 0.82 (0.55-1.23) | 0.90 (0.66-1.24) | 0.74 (0.40-1.37) |
Men nested | 0.92 (0.50-1.67) | 1.47 (0.96-2.25) | 1.52 (0.92-2.51) | 1.96 (1.35-2.85) | 1.74 (1.17-2.59) | |
Psoriasis | Women nested | 0.84 (0.29-2.43) | 1.05 (0.60-1.82) | 1.48 (0.83-2.66) | 2.02 (1.14-3.58) | 1.70 (0.77-3.73) |
Men nested | 1.44 (0.73-2.86) | 2.02 (1.20-3.39) | 0.60 (0.25-1.42) | 1.33 (0.82-2.17) | 1.30 (0.76-2.21) | |
Urinary tract infections | Women nested | 1.68 (1.11-2.54) | 1.44 (1.16-1.79) | 0.94 (0.72-1.22) | 1.47 (1.19-1.81) | 1.30 (0.89-1.89) |
Men nested | 1.26 (0.63-2.51) | 0.99 (0.55-1.76) | 2.13 (1.19-3.82) | 1.63 (1.00-2.65) | 1.04 (0.61-1.79) |
- Citation: Ajdacic-Gross V, Aleksandrowicz A, Rodgers S, Mutsch M, Tesic A, Müller M, Kawohl W, Rössler W, Seifritz E, Castelao E, Strippoli MPF, Vandeleur C, von Känel R, Paolicelli R, Landolt MA, Witthauer C, Lieb R, Preisig M. Infectious, atopic and inflammatory diseases, childhood adversities and familial aggregation are independently associated with the risk for mental disorders: Results from a large Swiss epidemiological study. World J Psychiatr 2016; 6(4): 419-430
- URL: https://www.wjgnet.com/2220-3206/full/v6/i4/419.htm
- DOI: https://dx.doi.org/10.5498/wjp.v6.i4.419